Infectious diseases are associated with a high morbidity and mortality rate among pediatric
cancer patients undergoing treatment or receiving a transplant. Neutropenia represents a …

Background Pediatric oncology patients have high rates of hospital readmission but there is
a dearth of research into risk factors for unplanned 30‐day readmissions among this high …

Objectives: As access to cancer care has improved throughout sub-Saharan Africa,
treatment-associated infections have increased. Assessing healthcare worker knowledge of …

Introduction Febrile neutropenia is an oncological emergency in children with cancer,
associated with serious infections and complications. In low-resourced settings, death from …

Background: Bloodstream infections are serious complications in neutropenic cancer
patients. There has been a universal pickup in multidrug resistant (MDR) strains. For …

Background Neutropenic fever (NF) is associated with significant morbidity and mortality for
patients receiving cancer treatment in sub-Saharan Africa (sSA). However, the antibiotic …

Background: Children with cancer have increased vulnerability to infections. Prompt
initiation of empiric antibiotics for fever episodes as guided by local antimicrobial sensitivity …

Background Febrile neutropenia (FN) is the commonest acute complication of cancer
treatment in children. The identification of patients at risk for FN as well as adverse outcomes …

Objetivo: La neutropenia febril es una complicación frecuente en pacientes hemato-
oncológicos al recibir quimioterapia, con una morbi-mortalidad importante. En América …

Febrile neutropenia (FN) in cancer pediatric patients is a serious fatal condition complicating
cancer treatment which results to increased morbidity and mortality. Moreover, FN is a …